ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO.
about
Adult venovenous extracorporeal membrane oxygenation for severe respiratory failure: Current status and future perspectivesPharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.Optimal management of the critically ill: anaesthesia, monitoring, data capture, and point-of-care technological practices in ovine models of critical care.Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation.Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort studyThe combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort studyAntibiotics and extracorporeal circulation--one size does not fit allProtein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study.Designing drug regimens for special intensive care unit populations.Ketamine infusion for patients receiving extracorporeal membrane oxygenation support: a case seriesTrough Concentrations of Vancomycin in Patients Undergoing Extracorporeal Membrane Oxygenation.Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation.Population pharmacokinetics of intravenous clonidine for sedation during paediatric extracorporeal membrane oxygenation and continuous venovenous hemofiltration.Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.Medicating patients during extracorporeal membrane oxygenation: the evidence is building.Critical Care Medicine 2017: Bigger Picture, Better Future.Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation.High-Dose Sedation and Analgesia During Extracorporeal Membrane Oxygenation: A Focus on the Adjunctive Use of Ketamine.Long-Term Quality of Life After Extracorporeal Membrane Oxygenation in ARDS Survivors: Systematic Review and Meta-Analysis.Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics.Evaluation of Meropenem Pharmacokinetics in an Experimental Acute Respiratory Distress Syndrome (ARDS) Model during Extracorporeal Membrane Oxygenation (ECMO) by Using a PenP β-Lactamase Biosensor.Optimising drug dosing in patients receiving extracorporeal membrane oxygenation.
P2860
Q28075285-353B4C87-8594-4859-B00F-76871F82672BQ30249512-14FF3429-EE11-461A-B08B-BCC6D9C22C96Q30811829-340FBCD8-CCAE-41F0-B69A-72C5BB2DB76BQ31032098-C2C42C43-D987-489C-B591-C2EE42F042E8Q34630847-D3A41709-A0A5-4D62-B726-FCF3018B61D3Q34636783-E2992DCA-7AAE-44A5-9F4C-B382ED4B44CBQ34996307-ACFF0068-38DD-4BB7-BB31-0F56AC6DE045Q35091940-FDB371E3-1209-4D10-9541-61EA51318604Q35530267-CBB69115-C2B8-40B9-8E0F-E69DBDBEE8D6Q35544079-CF3A7494-EF0E-41CD-8FE3-104151728E18Q35953787-406B4CA9-4522-42B8-8E28-2D24C5F1F9ECQ36257532-BBF10D47-C2E3-4AAA-83CD-588177E83A83Q38520159-D28FB2E8-AA6D-4869-807F-ADEB276CD966Q39025601-620B67D2-5B13-4BB0-B2F1-171652B32123Q39033001-67FEBF0D-7C55-4C88-984D-881B5A0AE7A1Q39188586-12E9CA82-F97A-42E7-B0BB-12537761102BQ42346902-373F24D0-3DDC-498C-B7A1-809876136943Q47152342-1336EBB2-C7F7-4061-9F7F-BD0A720608CFQ47591928-2DF3B1A8-DCF0-4BD0-90D5-F4FA152BD539Q47734210-981B7DBD-FE7F-4AEE-8289-8244CA5D14CBQ55145216-5CAFAD8E-23B2-474B-A069-18175FDF0D5AQ55259886-1677211B-BE21-4771-9C05-D4A63B1369E2Q55393633-B538A791-7135-4C4D-BF75-FA1F836FFF9B
P2860
ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
ASAP ECMO: Antibiotic, Sedativ ...... mise drug therapy during ECMO.
@ast
ASAP ECMO: Antibiotic, Sedativ ...... mise drug therapy during ECMO.
@en
ASAP ECMO: Antibiotic, Sedativ ...... mise drug therapy during ECMO.
@nl
type
label
ASAP ECMO: Antibiotic, Sedativ ...... mise drug therapy during ECMO.
@ast
ASAP ECMO: Antibiotic, Sedativ ...... mise drug therapy during ECMO.
@en
ASAP ECMO: Antibiotic, Sedativ ...... mise drug therapy during ECMO.
@nl
prefLabel
ASAP ECMO: Antibiotic, Sedativ ...... mise drug therapy during ECMO.
@ast
ASAP ECMO: Antibiotic, Sedativ ...... mise drug therapy during ECMO.
@en
ASAP ECMO: Antibiotic, Sedativ ...... mise drug therapy during ECMO.
@nl
P2093
P2860
P50
P356
P1433
P1476
ASAP ECMO: Antibiotic, Sedativ ...... mise drug therapy during ECMO.
@en
P2093
Daniel V Mullany
Eileen Gilder
Fay Burrows
James Walsham
John F Fraser
Rachael Parke
Sam Rudham
Shay McGuinness
Susan Welch
Sussan Ghassabian
P2860
P2888
P356
10.1186/1471-2253-12-29
P50
P577
2012-11-28T00:00:00Z
P5875
P6179
1039678577